CXCL8 and chronic obstructive pulmonary disease: We previously reported that IL-17A in the airways of COPD patients induces chromatin remodeling and promotes the release of IL-8 in the bronchial epithelium and that anticholinergic drugs are able to control this proinflammatory activity20.